GLA
AGIO icon

Great Lakes Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Great Lakes Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-389,071
Closed -$21.4M – 690
2021
Q2 		$21.4M Sell
389,071
-2,288
-0.6% -$128K 0.32% 96
2021
Q1 		$20.2M Buy
391,359
+24,660
+7% +$1.22M 0.33% 94
2020
Q4 		$15.9M Sell
366,699
-20,191
-5% -$798K 0.29% 112
2020
Q3 		$13.5M Buy
386,890
+62,927
+19% +$2.76M 0.29% 113
2020
Q2 		$17.3M Buy
+323,963
New +$15M 0.42% 72

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Great Lakes Advisors's AGIO Position: Q3 2021 in Review

Great Lakes Advisors sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 389,071 shares — an estimated $21.4M sold.

Great Lakes Advisors first reported a position in AGIO in Q2 2020 and held it in 5 quarters. The position peaked at $21.4M in Q2 2021. 164 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Great Lakes Advisors reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Great Lakes Advisors sold 389,071 Agios Pharmaceuticals shares in Q3 2021, an estimated $21.4M.
  • Great Lakes Advisors first reported a position in Agios Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Great Lakes Advisors's Agios Pharmaceuticals position peaked at $21.4M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Great Lakes Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.